Karen Akinsanya

Affiliations

  • Director at Nautilus Biotechnology Inc. (NAUT), 2025-06-25
  • President Of R&D, Therapeutics at Schrodinger Inc. (SDGR), 2025-04-15
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SDGR $25.00 3,345 $83,625.00 15,625 2025-04-14 Filing
SDGR $25.11 5,000 $125,554.50 18,970 2025-04-14 Filing
SDGR $25.11 8,378 $210,390.85 23,970 2025-04-14 Filing
SDGR $55.75 1,393 $77,659.75 0 2021-10-15 Filing
SDGR $61.13 1,394 $85,215.22 0 2021-09-15 Filing